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Main Text  
Introduction 
Ankle-foot orthoses (AFOs) are externally applied devices that encompass the joints of the 
ankle and foot.  They are used to modify the structure and function of the neuromuscular and 
skeletal systems [1] and are used to manage mobility disabilities caused by a wide range of 
conditions such as stroke, cerebral palsy, spina bifida,  poliomyelitis and peripheral nerve 
injury[2-6]. AFOs have been shown to improve timed walking speed, step length and clearance 
of the toe in the swing phase of gait. [2,3,5,7-14]. Whilst these outcome measures are valuable 
in providing evidence for orthotic intervention, they focus on specific aspects of physical activity 
that can be measured in a gait laboratory.  Consequently, they do not provide any information 
about patients¶ use of AFOs in their day to day lives or the extent to which use of AFOs is 
associated with physical, psychological and social well-being. These outcomes are important 
because they are of value to the patient. Specifically, consideration of psychological well±being 
is vital because of its relationship with functional outcomes [15,16]. This paper adds to the 
literature by focusing on AFO use in a real life setting and by incorporating psychological 
measures to investigate differences in impairment, activity limitation and participation restriction 
across 3 groups of AFO users; people using AFOs as recommended, people using AFOs 
differently to recommended; and those not aware of recommendations for use.  
Use of AFOs 
To identify differences in outcomes across these groups, consideration should be given to other 
factors that could affect AFO use. Seriousness of the underlying health condition has been 
related to AFO use. Increased severity of Charcot-Marie-Tooth (CMT) disease [17] and greater 
functional impairment in stroke have also been related to increased use of AFOs by patients 
[18]. In addition, when provided with an orthosis a patient should be given specific wearing 
instructions [19], as recommended wear time may differ dependiQJ RQ D SHUVRQ¶V LQGLYLGXDO
circumstances. It is important that people follow the recommended wear times given by the 
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orthotist as over use may negatively affect functional outcome [20], and under-use or non-use 
can lead to falls [21], progression of deformity [22], and ulceration [23]. Despite this, adherence 
rates are varied with Vinci [21] reporting compliance to AFOs as low as 20% for patients with 
CMT disease. He noted that people chose not to use orthoses because they highlighted their 
disability and caused discomfort. Also Bakker [24] showed a discrepancy between 
recommended use and actual use, reporting that 18 out of 25 patients with Duchenne Muscular 
Dystrophy did not use their AFOs for the recommended amount of time, with all of these 
participants using the AFO less than recommended. This was thought to be due to pain and 
patient reluctance to wear the orthotic devices; however reasons for their reluctance were not 
formally investigated. In summary, appropriate use of orthoses is important for optimal 
outcomes.  
Identification of Health Outcomes 
A theoretical approach to understanding use of AFOs and their impact on patient valued 
outcomes would be useful. Use of a theoretical framework of health outcomes would facilitate 
the identification of appropriate outcome measures and therefore offers a more structured 
approach to the development of future interventions [25].   
The International Classification of Functioning, Disability and Health (ICF) [26], shown in 
Figure 1, identifies three distinct health outcomes, namely, impairments to body functions and 
structures, activity limitations (i.e. limitations in the ability to perform specific actions) and 
participation restrictions (i.e. restrictions in involvement in life situations).  The three health 
outcomes are interrelated and are all influenced by personal and environmental contextual 
factors.  Therefore the ICF can be used as a framework to examine the impact of health 
interventions on specific outcomes; impairment, activity limitation and participation restriction 
[27,28].  
Insert Figure 1 here 
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Measurement of impairment, activity limitation and participation restrictions  
When selecting outcome measures, it is important to ensure that outcomes measure the 
specific construct and do not overlap other constructs in the same theory [29].  If there is poor 
content validity and the measures used in a study do not discriminate among constructs, any 
identified relationships may be of questionable value [30].    
A candidate core set of outcome measures has been proposed to assess outcomes for 
lower limb orthotic interventions [31]. These core sets can be used to define impairment, activity 
limitation or participation restriction [32]. For example, Brehm [31] suggests that appropriate 
outcomes for the impairment component of the ICF could be gait pattern functions, pain, and 
exercise tolerance functions. Mobility and moving around in different locations could be used to 
measure activity limitation, and community, social and interpersonal interactions could be used 
to measure participation restrictions. However, although the most successful results are 
achieved in well-motivated patients [31], it appears an anomaly that psychological well-being 
measures are not considered as part of a core set of outcome measures in orthotic studies. As 
well as obvious physical factors, studies have shown that psychological factors, such as 
emotional well-being, cognitions and coping mechanisms can affect functional outcome [33-36]. 
Within the ICF psychological well-being indicators such as depression and anxiety are classified 
as impairments to the cognitive system. However standardised measures of psychological well-
being or distress have rarely been reported in orthotic studies, and have generally focused on 
more complex orthoses for spinal cord injury (SCI) [37] or multidisciplinary interventions [35] 
including orthotic management. In summary, although there is some evidence that orthotic use 
is related to psychological and social well- being, few studies have used psychological well-
being and distress as an outcome measure.  
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Aims and Hypotheses 
The aims of this study were to investigate differences in impairment, activity limitation and 
participation restriction and psychological distress in 3 groups: participants who used AFOs as 
recommended, participants who did not use as recommended, and participants who were not 
aware of recommendations for use. The following hypotheses were tested: 
1. participants using their AFOs as recommended will report lower levels of impairment 
than participants not using their AFOs as recommended;  
2. participants using their AFOs as recommended will report lower levels activity limitation 
than participants not using their AFOs as recommended;  
3. participants using their AFOs as recommended will report lower levels of participation 
restriction than participants not using their AFOs as recommended;  
4. Participants using their AFOs as recommended will report lower levels of anxiety and 
depression than participants not using their AFOs as recommended. 
Method  
Participants  
Participants were 157 patients who had been fitted with an AFO between 2010 and 2012 from 
an NHS Orthotic Service in Scotland, to manage a functional deficit affecting their lower limb.  
All participants were aged 18 years old or over. The mean age of the sample was 59 years old 
(SD 16.3) and 46% (n=72) were male. Participants could have been prescribed  an AFO for any 
condition. 53.6% of participants were prescribed an AFO because of a  condition caused by 
damage to the brain (e.g. stroke, multiple sclerosis, traumatic brain injury) and the remaining 
participants were prescribed an AFO because of damage to another part of the body (e.g. 
peripheral nerve injury, bone or soft tissue damage).  
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The mean length of time since the AFOs were fitted to participants was 19.1 (SD 11.8) months. 
Forty one percent of the participants (n=64) had AFOs which were fitted to the right leg; 42.7% 
(n=67) to the left leg and 16.6% (n=26) to both legs. A total of 183 AFOs were fitted to the 
sample with the following designs being used: rigid 60.7% (n=111); flexible 29.5% (n=54); 
ground reaction 2.2% (n=4); jointed 2.2% (n=4); other 2.2% (n=4); unknown 3.3% (n=6). 
Seventy one percent (n=130) of AFOs were custom made; 19.7% (n=36) were prefabricated; for 
9.3% (n=17) of AFOs, it was not known if devices were custom made or prefabricated.  
Forty one per cent of the participants (n = 64) reported that they used their AFO as 
recommended; 32% (n=51) reported that they did not use their AFO as recommended (29/51 
reported that they did not use their AFO at all, 13/51 reported using it more than recommended 
and 9/51 reported using it less than recommended); 27% (n=42) did not know the 
recommendations for use, although all of these participants reported that they were using their 
AFO. A MANOVA showed that there were no significant differences between non-, under- and 
over-users on any of the outcome measures, F (24, 74) = 0.916, ns, (univariate Fs (2, 48) = 
0.08 to 1.32, ns).  Therefore, in the subsequent analyses these participants were combined into 
the one group, against which we compared the participants who used their AFOs as 
recommended and those who did not know the recommendations for use.   
Design and Procedure  
A cross-sectional design was used. Postal questionnaires were sent to a consecutive sample of 
n=966 adults, drawn from a database held by the Orthotics Service. The questionnaires asked 
participants to provide information about their demographic and clinical status, their AFO usage, 
and contained established scales to measure a range of health outcomes that (a) have 
previously been used to measure the three ICF health outcomes; impairments, activity 
limitations and participation restrictions, and psychological distress, and (b) could potentially be 
improved through use of an AFO by patients with a functional impairment of the lower limb.  The 
questionnaire was sent by the Orthotics Service along with an information sheet about the 
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study.  The information sheet stated that participation was voluntary, that there were no right or 
wrong answers to any of the questions, and that all information would be treated confidentially, 
and participants were encouraged to answer honestly. Participants returned their completed 
questionnaire to the research team at the University of Strathclyde using an enclosed stamped 
addressed envelope. One hundred and sixty one participants (17%) returned the questionnaire. 
This response rate is broadly comparable with previous postal surveys of patient groups with 
complex health conditions [38,39].  Out of the 161 participants who responded, 4 did not 
indicate if they used their orthoses as recommended, and were excluded from any further 
analysis leaving a final sample of 157. Ethical approval for this study was obtained from NHS 
West of Scotland Research Ethics Committee (11/AL/0263) and the University of Strathclyde 
Ethics Committee (UEC 110102).  
Measures 
Demographic and Clinical Measures   
Participants were asked to state their age, gender, and postcode sector. Postcode sector was 
recoded into a deprivation score, using the Carstairs Scores, a measure which reflects access 
to material resources [40]. These scores provide a summary measure applied to populations 
rather than a measure of deprivation experienced by an individual. These scores ranged from 1, 
the most affluent postcode sector to 7, the most deprived. Participants were also asked to state 
the condition which led to them being prescribed an AFO, and any co-morbidities that they had.  
Participants were asked to rate the perceived seriousness of their primary condition for which 
the AFO was prescribed and perceived seriousness of any co-morbidities on a scale of 0 to 3, 
with 0 being not serious at all and 3 being extremely serious. Perceived seriousness of condition 
is known to affect physical and psychological health outcomes across a number of conditions 
[41,42].  Furthermore, many patients using AFOs present with co-morbidities which could also 
explain higher levels of impairment and activity limitations. 
Impairments 
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Items from the RAND-36 Item Short Form Health Survey [43] were used to measure 4 aspects 
of impairment namely: General Health Impairment (items 1, 33, 34, 35, 36); pain impairment 
(items 21,22); Fatigue/energy impairment (items 23,27,29,31); and impairment to emotional 
wellbeing (items 24,25,26,28,30). All these impairment outcomes have been shown to measure 
impairment with discriminant validity [44]. The RAND-36 is an established measure of health-
related quality of life in which responses to every item are coded from 0 to 100. The mean of all 
items in the same sub-scale is used as a composite measure for subsequent analyses.  All 
items are scored so that a more positive score indicates a more favourable health status. Five 
LWHPVPHDVXUHJHQHUDOKHDOWKHJ³,QJHQHUDOZRXOG\RXVD\\RXUKHDOWKLVH[FHOOHQW>VFRUHG
@YHU\JRRG>VFRUHG@JRRG>VFRUHG@IDLU>VFRUHG@RUSRRU>VFRUHG@´7ZRLWHPV
measure pain HJ³+RZmuch bodily pain have you had during the past 4 weeks: none [scored 
100], very mild [scored 80], mild [scored 60], moderate [scored 40], severe [scored 20] or very 
VHYHUH>VFRUHG@´)RXULWHPVPHDVXUHHQHUJ\IDWLJXHHJ³'LG\RXKDYHDORWRIHQHUJ\ all 
of the time [scored 100], most of the time [scored 80], a good bit of the time [scored 60], some 
RI WKH WLPH>VFRUHG@D OLWWOHELWRI WKH WLPH >VFRUHG@QRQHRI WKH WLPH>VFRUHG@´ )LYH
items measure emotional well-being (e.g. ³How much of the time during the past 4 weeks have 
you felt calm and peaceful?: all of the time [100], most of the time [80], a good bit of the time 
>@ VRPH RI WKH WLPH >@ D OLWWOH RI WKH WLPH >@ QRQH RI WKH WLPH >@´7KH PHDQ RI WKH
general health items produced a reliable composite VFDOHĮ DVGLGWKHPHDQRIWKHSDLQ
Į WKHHQHUJ\IDWLJXHĮ DQGWKHHPRWLRQDOZHOO-EHLQJĮ LWHPV 
Activity Limitations 
Seven items from the RAND-36 (items 6-12) physical functioning sub-scale were used to 
measure activity limitations with discriminant validity Į  1). These items measured the 
H[WHQW WRZKLFKSDUWLFLSDQW¶VKHDOWK OLPLWVWKHPLQDUDQJHRIDFWLYLWLHV HJ³Does your health 
now limit you in walking several blocks (about ½ a mile): a lot [scored 0], a little [scored 50], Not 
at all [VFRUHG @´ Questions 3-5 in the RAND 36 have been identified as reflecting a 
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combination of both impairment and activity limitation constructs and were therefore not 
considered to be pure measures of activity limitation and were not included in the analysis [44]. 
Participation Restrictions 
Participation (i.e. involvement in life situations) was measured using the social functioning sub 
scale of the RAND-36 (items 20,32)ZKLFKFRQWDLQVLWHPVĮ HJ³During the past 4 
weeks, how much of the time has your physical health or emotional problems interfered with 
your social activities: all of the time [ scored 0], most of the time [scored 20], some of the time 
[scored 50], a little bit of the time [scored 75], none of the time [scored @´ 
Mixed Measures ±Activity limitations and Participation Restrictions  
The RAND-36 contains items that measure both activity limitations and participation restrictions.  
These mixed items were scored separately from the pure activity and participation items. These 
measures were role limitations due to physical health problems (items 13-16) and role 
limitations due to emotional problems (items 17-19). . )RXU LWHPV Į   PHDVXUHG role 
limitations due to physical health problems HJ ³'XULQJ WKH SDVW  ZHHNV KDYH \RX
accomplished less than you would like as a result of your physical health: Yes [scored 0], No 
>VFRUHG@´7KUHHLWHPVĮ PHDVXUHGrole limitations due to emotional problems (e.g., 
³'XULQJWKHSDVWZHHNVKDYH\RXFXWGRZQWKHDPRXQWRI WLPH\RXVSHQWRQZRUNRURWKHU
DFWLYLWLHVDVDUHVXOWRIDQ\HPRWLRQDOSUREOHPV<HV>VFRUHG@1R>VFRUHG@´ 
Psychological Distress - Hospital Anxiety and Depression Scale (HADS) 
The HADS [45] was used to measure anxiety and depression; two further indicators of 
psychological impairment. The HADS includes 14 items; each measured on a 4-point scale and 
scored from 0-3. Seven items measure anxiety (e.g., ", FDQ VLW DW HDVH DQG IHHO UHOD[HG´
definitely [scored 3]; usually [scored 2]; not often [scored1]; not at all [scored 0]) and 7 items 
PHDVXUHGHSUHVVLRQHJ³,IHHOFKHHUIXO´QRWDWall [scored 3]; not often [scored 2]; sometimes 
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[scored 1]; or most of the time [scored 0]. The sum of the 7 anxiety items (Į DQGWKHVXP
of the 7 GHSUHVVLRQLWHPVĮ 86) produced reliable composite scales.  
Statistical Analysis 
All questionnaire data were coded and entered into SPSS® Version 20. Descriptive statistics 
(means and standard deviations) were computed for all measures for the full sample and 
separately for participants who used their AFOs as recommended, those who did not use as 
recommended and those who did not know recommendations for use. Differences between 
these groups in demographic, clinical status and the three health outcomes (impairment, activity 
limitations and participation restrictions) were tested using a series of between-subjects 
Analyses Of Variance (ANOVA) for continuous data, DQG3HDUVRQ¶VFKLVTXDUHGWHVWIRUQRPLQDO
data. Planned follow up comparisons were used to test the primary hypotheses using between 
subjects t-tests. Alpha was set DWĮ  for all statistical tests.  
Results  
Demographic and Clinical Characteristics of Sample 
The demographic and clinical characteristics of the 3 groups are shown in Table 1.  
Insert Table 1 here 
There were no significant differences in demographic or clinical characteristics between 
participants who used their AFO as recommended, those who did not use their AFO as 
recommended and those who did not know recommendations for use. Therefore, the 
subsequently reported differences between these participant groups on the ICF outcomes and 
HADS cannot be attributed to any between-group differences in demographic or clinical status.  
Descriptive Statistics  
 11 
 
The means and standard deviations in Table 2 show that the sample as a whole scored below 
the scale mid-points for energy levels, general health, physical functioning and role limitations 
due to physical problems indicating that the sample in general had moderate to low levels of 
general health, energy and physical functioning and a high level of role limitations due to 
physical problems. The sample means were above the scale mid-points for pain, social 
functioning, role limitations due to emotional problems and emotional well-being indicating that 
the sample, on average, had moderate levels of pain, moderate to high levels of social 
functioning, high levels of emotional well-being and a low to moderate level of role limitations 
due to emotional problems. The mean anxiety and depression scores as measured by HADS 
were below 8, the value at which clinical levels of anxiety and depression are considered 
present, indicating that on average participants did not experience clinical levels of anxiety and 
depression [45].   
In line with the study hypotheses, participants who used their AFO as recommended 
reported less impairment, lower activity limitations and lower participation restrictions than those 
who did not use their AFO as recommended and those who did not know recommendations for 
use.   
Insert Table 2 here 
Testing between group differences in impairment, activity limitation, participation 
restriction and psychological distress 
There were significant between-group differences in one measure of impairment, namely 
energy/ fatigue F(2,147)= 3.45, p=0.03, CRKHQ¶VI  (see Table 2). In line with hypothesis 1, 
planned comparisons indicated that participants using AFOs as recommended reported 
significantly higher levels of energy t(df=147)=2.57, p<0.01, d=0.64 than participants not using 
AFOs as recommended. There were also significant between group differences in activity 
levels, as measured by physical functioning, F(2,146)= 3.95, p=0.02, CRKHQ¶V I . In line 
with hypothesis 2, follow-up t-tests demonstrated that participants using AFOs as 
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recommended reported higher physical functioning t(df =146)= 2.57, p<0.01, d=0.63. Contrary 
to hypothesis 3, we did not find any differences in the pure construct of participation 
restrictions, as measured by social functioning between the three groups. Role limitations due 
to emotional problems F(2,125)= 5.27, p  &RKHQ¶V I  GHPRQVWUDWHG D VLJQLILFDQW
difference between groups. Follow-up t-tests indicated lower role limitations due to emotional 
problems t(df=89.54)=3.25, p<0.01, d=0.91. However because this is a combined measure of 
activity and participation, hypothesis 3 was not supported. There was a significant between-
group difference in anxiety F(2,148)= 3.70, p &RKHQ¶VI 0.22 (see Table 2). Follow-up t-
tests indicated and significantly lower levels of anxiety t(df=148)=2.71, p<0.01, d=0.91, 
providing some support for hypothesis 4. 
Discussion 
The aims of this study were to investigate differences in the three ICF outcomes of impairment, 
activity limitation and participation restriction, and psychological distress in participants using 
AFOs as recommended, participants who did not use AFOs as recommended, and participants 
not aware of recommendations for use. Specifically, differences between participants using 
AFOs as recommended and those not using AFOs as recommended were examined.  
For impairment outcomes, participants using their AFO as recommended reported 
higher levels of energy (a medium to large effect size [46]), when compared to participants who 
did not use AFOs as recommended. The pDWLHQWV¶ higher energy levels are supported by 
experimental studies of AFO use which have found reduced energy expenditure when walking 
with AFOs [14,47,48]. In this study, people using AFOs as recommended did not report lower 
pain levels compared to the other 2 groups. In contrast, reduction in pain following use of AFOs 
has been reported in other studies [49-51] with Jagadamma [49] reporting the importance of 
appropriate tuning of the AFO-footwear combination in reducing knee pain. However, due to the 
research design, we were not able to ascertain if the AFOs had been appropriately tuned. Also, 
participants using their AFOs as recommended may actually use the AFO to reduce their pain to 
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a more manageable level; i.e. participants using AFOs as recommended may have a higher 
level of pain when not using their AFO, compared to the group who did not use AFOs as 
recommended, which may explain why we did not see any significant differences. There was no 
difference in general health between the groups. A generic measure of health in such a 
heterogeneous group, with a range of co-morbidities has value in providing an indicator of 
overall health status. However it may be too generic an outcome measure to be associated with 
AFO use.   
Participants who reported using their AFOs as recommended also reported lower activity 
limitations than those not using their AFOs as recommended. This finding is  consistent with a 
systematic review and pooled meta-analysis [52] demonstrating significant improvements in 
objective measures of balance and walking activity when using an AFO after stroke. Key 
measures used in this review, such as, timed walk tests (walking speed), timed up and go test 
(mobility), time to ascend and descend stairs (mobility), postural sway and weight distribution 
(balance), focus on the performance of the patient in the gait laboratory. The measure of 
physical functioning used in the current study captures use of AFOs while carrying out a range 
of activities of daily living,  and because it is a patient reported measure, may be more likely to 
be associated with WKHSDWLHQW¶VGHFLVLRQWRuse the AFO as recommended.   
Higher scores in role limitations due to emotional problems (a large effect size) were 
seen in participants who used AFOs as recommended meaning that daily activities were 
significantly less likely to be limited by emotional problems. However this measure is not a pure 
measure of activity limitation but a combination of activity and participation restrictions. Previous 
studies which have investigated role limitations due to emotional problems in people with 
mobility disabilities [53] have not specifically investigated any relationship with AFO use. While 
this is an important finding, the lack of discriminant validity poses challenges in understanding 
the relationship between ICF constructs.    
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Contrary to our hypothesis we did not find a significant difference in the pure measure 
participation restrictions between the three groups, as measured by social functioning. The lack 
of difference between groups however can be explained by consideration of the ICF model, 
which suggests that other factors, such as personal and environmental factors as well as 
impairment can influence social participation. Another possible reason for a lack of significance 
in this current study may be that people using AFOs as recommended may have lower 
participation levels if they do not use their AFOs as recommended, compared to the group who 
do not use as recommended, and this therefore is a motivation to use the AFO. A prospective 
study would be useful to investigate this. Lack of literature in this area does suggest that 
participation has been overlooked as an appropriate outcome measure and should be used 
more routinely.  
Participants using their AFO as recommended reported significantly lower levels of 
anxiety than participants who did not use their AFO (a large effect size [46]), although a 
difference in depression levels was not seen. Psychological outcomes in orthotics are rarely 
assessed. However an earlier descriptive study has shown that 58% of participants reported 
that AFO use was linked to reduced distress and 64% reported that the AFO made them feel 
better about themselves [2].  
In summary, lower levels of impairment, activity limitations and anxiety were found in 
people using AFOs as recommended compared to people not using AFOs as recommended, 
not explained by demographic or clinical differences. This suggests the need to investigate 
more specifically why appropriate AFOs use is associated with reduced impairment, activity 
limitations and anxiety; and to investigate why some people adhere to use of AFOs as 
recommended and others do not. This could offer potential opportunities to reduce impairment, 
and improve activity levels and psychological well-being by identification of strategies to 
increase the number of patients who use orthoses as recommended.  
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The high number of participants (n=42, 27%) who were not aware of recommendations 
for use of their AFO is worth comment. The way in which AFOs are used is of crucial 
importance in achieving the optimum outcome for patients. While acknowledging that some 
participants in this sample may also have had cognitive challenges, due to their underlying 
pathology, and may not have been able to recall recommendations for use, no differences in 
use were seen between participants whose condition was caused by brain damage and those 
whose condition was not. When compared with data reported in the Best Practice Statement of 
2008 [2], which found that approximately 50% of respondents claimed they did not get any 
information about the AFO and 40% felt they did not receive clear information, this figure of 27% 
suggests some improvement in information levels supplied to participants about their AFOs. 
However the high number of participants who remained unaware of recommendations for use 
highlights the need for improved communication and information, both verbal and written to 
assist patients in appropriate use of AFOs.  
Use of the ICF  
This study has explored differences between participants who used AFOs as recommended and 
those who do not, using the ICF to identify outcome measures. There is still much work to be 
done in how the ICF components can be effectively operationalized and related specifically to 
orthotic use. The relationship between impairment, activity limitations and participation are 
complex, with the personal and environmental factors adding increased complexity. The role of 
personal and environmental factors allow the possibility that interventions which aim to reduce 
impairment, may  have a weak impact on activity limitation and participation restriction, and may 
only affect participation indirectly [54]. Brehm noted that currently there is no consensus on the 
most appropriate outcome measures, and further work is needed to identify suitability of 
instruments to the context being investigated [31]. The results of this study suggest the need to 
incorporate psychological health and well-being measures from the ICF such as energy and 
drive, and emotional functions to better understand AFO use. The SDWLHQW¶VGHFLVLRQWRXVH an 
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AFO can be considered a behaviour, and therefore psychological theories may also be useful in 
understanding AFO use and adherence, particularly the cognitive processes underlying AFO 
use. Therefore further studies investigating AFO use should consider use of social cognitive 
theories or an integrated ICF model which includes psychological theory [55,56].   
Limitations 
This study is the first study, to our knowledge, to explore differences in ICF outcomes of 
impairment, activity limitation and participation restrictions in different groups of AFO users. 
However this study has a number of limitations. The cross sectional nature of design does not 
allow causation to be identified. The response rate of 17% suggests that caution should be used 
in interpreting the results, due to possible sampling bias. The poor response rate may be 
indicative of a patient group with a high level of physical and psychological co-morbidities which 
is difficult to recruit. However, a large sample size was selected to deal with an expected low 
response rate and the number of participants (n=157) is considered a large group of participants 
for a study about AFOs, compared to other surveys [2,57,58]. Furthermore we consider 
inclusion of non-users of AFOs as an important strength of this study. Non-users, people who 
have been prescribed orthoses but choose not to use them, are a challenging group to recruit, 
and also are unlikely to obtain any benefit in participating, but their inclusion has allowed us to 
identify important differences between the groups.   
Another limitation was that this research was carried out with participants living in a 
particular area of Scotland, who were provided with AFOs from one orthotic department. 
Therefore we cannot be sure if the findings would be generalisable to other locations in 
Scotland, or elsewhere in the UK. As with any questionnaire design, participants in this study 
used self-reported measures of use. However we feel that participant anonymity and wording in 
the questionnaire ³0DQ\SHRSOHILQGDZD\RIXVLQJWKHLU orthoses which suits them, or choose 
QRWWRXVHWKHP7KLVPD\GLIIHUIURPWKHLQVWUXFWLRQV\RXKDYHEHHQJLYHQ´, may have allowed 
an honest response regarding use from participants. 
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While use of AFOs as recommended is recognised as important to outcomes, 
UHFRPPHQGDWLRQVIRUXVHWHQGWREHEDVHGRQRUWKRWLVWV¶H[SHULHQFHUDWKHUWKDQHYLGHQFH$Q
assumption was made that orthotists who fitted the AFOs gave appropriate instructions 
regarding use, and we believe this to be a reasonable assumption. However, this does highlight 
the need for evidence relating to optimal wearing times for AFOs. Finally it is not possible to 
comment on the fit or function of the AFOs supplied in this study given the research design. 
Visual assessment of fit and appropriate function would be necessary to control for these factors 
in a prospective study.  
Conclusion 
The ICF has been used as a framework to explore differences in impairment, activity limitation 
and participation restrictions between participants who used AFOs as recommended, those who 
did not use as recommended and those who did not know recommendations for use. This study 
has demonstrated significantly lower impairment, as measured by higher energy levels, and 
lower anxiety in people who use AFOs as recommended; lower activity limitations as measured 
by physical functioning, and role limitations due to emotional problems which crosses both 
activity limitations and participation restrictions. Depending on the individual, an orthosis may be 
either a barrier or a facilitator to a range of activities. Further investigation is required to 
understand the relationship between psychological variables and AFO use, with a view to 
developing orthotic interventions WKDW DOVR FRQVLGHU DQ LQGLYLGXDO¶V SV\FKRORJLFDO VWDWXV 7KLV
may allow increased use of AFOs and other types of orthotic management as recommended 
and therefore positively impact on functioning, activity levels, participation, and psychological 
well-being of orthotic users.  
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Tables with Captions  
 
Table 1: Comparison of Demographic and Clinical Variables between participants using AFOs 
as recommended, participants not using AFOs as recommended, and participants who did not 
know recommendations for use  
 
 
 
 
 Full Sample 
(n=157) 
AFO used as 
recommended 
(n=64) 
AFO not used as 
recommended 
(n=51) 
Did not know 
recommendations 
for use 
(n=42) 
Ȥð) p 
Gender:       
Male     (n (%)) 
Female (n (%)) 
72 (45.9%) 
85 (54.1%) 
35 (64.8%) 
29 (43.9%) 
19 (35.2%) 
32 (56.1%) 
18 (42.9%) 
24 (57.1%) 
3.68 0.16 
Age 59.0 (SD 16.3) 59.6 (SD 16.5) 58.5 (SD 16.5) 58.8 (SD 16.3) 0.06 0.94 
Deprivation score  4.4 (SD 1.9) 4.4 (SD 1.9) 4.3 (SD 2.0) 4.26 (SD 1.9) 0.09 0.91 
Condition:        
Condition caused by 
damage to brain (n (%)) 
82 (53.6%) 31 (20.3%) 27 (17.6%) 24 (15.7%) 
0.94 0.63 Condition caused by 
damage to other parts of 
the body (n (%)) 
71 (46.4%) 32 (20.9%) 22 (14.4%) 17 (11.1%) 
Self -reported 
seriousness of condition 
2.25 (SD 0.61) 2.30 (SD 0.59) 2.29 (SD 0.61) 2.12 (SD 0.63) 1.34 0.26 
Number of co-
morbidities 
1.56 (SD 1.39) 1.52 (SD 1.47) 1.70 (SD 1.30) 1.46 (SD 1.40) 0.38 0.69 
Self- reported 
seriousness of co-
morbidities  
1.87 (SD 0.68) 1.93 (SD 0.76) 1.85 (SD 0.70) 1.82 (SD 0.55) 0.21 0.81 
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Construct  Measure 
Mean (SD) 
F p &RKHQ¶Vf 
Full 
Sample 
AFO used as 
recommended 
AFO not used as 
recommended 
Did not know 
recommendations 
for use 
I  
 
General Health 44.4 (24.9) 47.4 (25.6) 41.9 (24.8) 42.9 (24.0) 0.74 0.48 0.10 
 Pain 51.6 (30.9) 53.9 (30.8) 48.8 (30.4) 51.6 (32.1) 0.38 0.69 0.07 
 Energy/ Fatigue 39.4 (20.9) 43.4 (21.3) 33.2 (21.1) 40.8 (19.0) 3.45 0.03* 0.22 
 Emotional Well 
being  
66.3 (21.9) 68.9 (20.1) 61.3 (22.3) 68.4 (23.5) 1.83 0.16 0.16 
A 
 
Physical 
Functioning 
45.4 (33.8) 50.9 (34.8) 34.4 (29.6) 50.4 (34.7) 3.95 0.02* 0.23 
P 
 
Social 
Functioning 
56.5 (32.1) 60.5 (32.7) 51.2 (31.7) 56.9 (32.1) 1.17 0.31 0.12 
A & P 
 
Role  Limitations 
due to Physical 
Problems 
29.6 (37.8) 36.9 (42.5) 25.0 (32.7) 25.4 (36.4) 1.47 0.23 0.15 
 Role Limitations 
due to Emotional 
Problems 
58.1 (44.1) 73.8(40.5) 45.9 (41.6) 52.8 (46.7) 5.27 <0.01** 0.29 
Psychol. 
Distress 
Anxiety  7.3 (5.4) 6.1 (4.80) 8.8 (5.4) 7.1 (5.9) 3.70 0.03* 0.22 
 Depression           6.89 (4.62) 5.9 (4.1) 7.8 (5.0) 7.2 (4.7) 2.31 0.10 0.18 
 
Table 21: Between group ANOVAs testing differences between participants using AFOs as 
recommended, participants not using AFOs as recommended, and participants who did not know 
recommendations for use in measures of body functions and structure, activity and participation                 
* p < 0.05  ** p < 0.01 
 
 
                                                          
1 RAND 36 was used to measure impairment (I), activity limitations (A), participation restrictions (P) and combined 
measure of activity limitations and participation restrictions (A&P). HADS was used to measure psychological 
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Figures with Captions  
Figure 1: The International Classification of Functioning, Disability and Health  
 
